News
MVA-B Spanish HIV vaccine shows 90 percent immune response in humans
Wed, 09/28/2011 - 6:10am
MVA-B Spanish HIV vaccine shows 90 percent immune response in humans
Phase I clinical trials developed by Spanish Superior Scientific Research Council (CSIC) together with Gregorio Marañón Hospital in Madrid and Clínic Hospital in Barcelona, reveals MVA-B preventive vaccine's immune efficiency against Human's immunodeficiency virus (HIV).Topics
